Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14729150 | 0.86 | CDC25A (0.30) | — | |
| SCHEMBL11954578 | 0.84 | PTGS2 (0.31) | — | |
| SCHEMBL13932215 | 0.80 | ACHE (0.41) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL13932217 | 0.80 | ACHE (0.41) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL17828558 | 0.80 | NR4A2 (0.43) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL21705051 | 0.80 | GPR84 (0.35) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL13932289 | 0.79 | ACHE (0.41) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL13932219 | 0.79 | ADORA2A (0.37) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL13932281 | 0.79 | HAO2 (0.38) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E | |
| SCHEMBL133942 | 0.78 | NR4A2 (0.47) | CYP1A2CYP3A4CYP2C19ENPP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8900727-B2 | Condensed polycyclic compound, organic light-emitting device having the same, display device, image information processing device, lighting device, image formation device, and exposure light source | CANON KABUSHIKI KAISHA (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8900727-B2 | Condensed polycyclic compound, organic light-emitting device having the same, display device, image information processing device, lighting device, image formation device, and exposure light source | CANON KABUSHIKI KAISHA (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20130050561-A1 | NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE | CANON KABUSHIKI KAISHA (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130050561-A1 | NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE | CANON KABUSHIKI KAISHA (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130050561-A1 | NOVEL CONDENSED POLYCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME, DISPLAY DEVICE, IMAGE INFORMATION PROCESSING DEVICE, LIGHTING DEVICE, IMAGE FORMATION DEVICE, AND EXPOSURE LIGHT SOURCE | CCND2, CCNE2, C1R | CYP1A2 171/4885CYP3A4 1108/4885CYP2C19 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.